Humira® (Humira®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceAdalimumabAdalimumab
Similar drugsTo uncover
  • Humira®
    solution PC 
    EbbVi Ltd.     Russia
  • Humira®
    solution PC 
    EbbVi Ltd.     Russia
    • Dosage form: & nbsphypodermic solution
    ATX: & nbsp

    L.04.A.B.04   Adalimumab

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004593
    Date of registration:20.12.2017
    Expiration Date:20.12.2022
    The owner of the registration certificate:EbbVi Ltd.EbbVi Ltd. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp24.01.2018
    Illustrated instructions
      Instructions
      Up